Fundraising FoxMetiMedi
1 known investors
Find your way into MetiMedi
Sign up to see every warm intro you have to MetiMedi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MetiMedi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Metimedi Pharmaceuticals is a South Korean biopharmaceutical company developing calcium-based "booster" drugs, with a focus on refractory metastatic colorectal cancer and enhancing the efficacy of chemotherapy agents. It builds a research-driven pipeline for the pharmaceutical and healthcare industry.
Investors · 1
Frequently asked questions
- What does MetiMedi do?
- Metimedi Pharmaceuticals is a South Korean biopharmaceutical company developing calcium-based "booster" drugs, with a focus on refractory metastatic colorectal cancer and enhancing the efficacy of chemotherapy agents. It builds a research-driven pipeline for the pharmaceutical and healthcare industry.
- Who are MetiMedi's investors?
- MetiMedi's investors include Magna Investment.